Older people with confusion.

Area of Science:

• Medical Ethics
• Geriatric Medicine
• Pharmaceutical Care

Background:

• Individuals with dementia often face challenges regarding capacity and informed consent for medical treatments.
• Historically, covert medication administration has been employed in some clinical settings, raising ethical questions.
• Safeguards exist for medication administration, but patient refusal can present complex ethical dilemmas.

Purpose of the Study:

• To explore the ethical and legal implications of capacity and consent in medication administration for patients with dementia.
• To examine the shift from covert to transparent medication administration practices.
• To emphasize the importance of respecting patient autonomy and refusal of treatment.

Main Methods:

• Qualitative reflection on clinical experiences with patients diagnosed with dementia.
• Case vignette illustrating a critical incident involving patient refusal of medication.
• Ethical analysis of past practices versus current standards of care.

Main Results:

• Covert administration of medication, even with palatable additions, is ethically questionable.
• Patient refusal of medication, regardless of perceived capacity, necessitates a re-evaluation of administration methods.
• The incident served as a turning point, reinforcing the need for explicit consent.

Conclusions:

• Ethical practice in dementia care requires prioritizing informed consent and respecting patient autonomy.
• Covert medication administration is not a justifiable practice.
• Clinical protocols must adapt to ensure patient rights are upheld, especially concerning medication refusal.